The aim of our customer AICUBE is “to enhance the level of secondary prevention of several non-communicable diseases such as Type II diabetes. We support early diagnosis of disorders to help early and effective treatments, and reduce associated complications.
Secondary prevention can be implemented by measuring values of specific biomarkers on a daily or weekly basis to gain statistically significant data.
We have therefore patented and developed a device that collects a saliva sample in a non-invasive mode by means of an “augmented” electric toothbrush. The saliva sample is then sent to a unit (Base) that measures the value of the reference biomarker. In addition, the handset hosts an accelerometer for determining a tremor severity index for parkinsonian patients.“